Savara Inc

SVRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2020 FY2019 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
Revenue $257.0K $0 $0 $400.0K $54.0K $0 $0 $0
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $14.3M $13.1M $11.1M $9.3M $11.0M $9.5M $8.5M $7.5M
Operating Income $-49.3M $-79.0M $-30.0M $-10.9M $-5.9M $-29.3M $-21.5M $-15.6M
Operating Margin -19,182.9% -2,737.0% -10,968.5%
Interest Expense $1.2M $452.0K $2.6M
Pretax Income $-49.6M $-78.2M $-33.4M $-11.3M $-9.0M $-28.7M
Income Tax Expense $-3.6M $-357.0K $0 $0 $0
Net Income $-49.6M $-78.2M $-29.8M $-10.9M $-9.0M $-28.7M $-21.5M $-15.6M
Net Margin -19,305.4% -2,730.8% -16,664.8%
EPS (Basic) $-0.84 $-1.95 $-1.76 $-5.62 $-9.48 $-0.23 $-0.28 $-0.33
EPS (Diluted) $-0.84 $-1.95 $-1.76 $-5.62 $-9.48 $-0.23 $-0.28 $-0.33
Shares Outstanding (Basic) 54.2M 50.8M 30.5M 3.2M 163.6M 159.5M 102.7M 46.3M
Shares Outstanding (Diluted) 54.2M 50.8M 30.5M 3.2M 163.6M 159.5M 102.7M 46.3M
Dividends Per Share
← Newer Page 1 of 2 Older →